About Gujarat Kidney and Super Speciality Ltd IPO

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.

The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.

The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).

Services:

  • Secondary Care Services: General and surgical treatments.

  • Tertiary Care Services: Super speciality surgical procedures.

Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.

As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.

Competitive Strengths:

  • Pre-eminence in renal sciences, with established sub-superspecialities in urology
  • Asset light business model with focus in central region of Gujarat
  • Ability to attract, retain skilled and experienced quality medical professionals
  • Track record of operating and financial performance and growth

Gujarat Kidney and Super Speciality Ltd IPO Subscription Breakdown

Investory CategorySubscription PercentageAmount Raised (₹ Crores)
Qualified Institutional Buyers (QIBs)75%16500000 crores
Non-Institutional Investors (NIIs15%3300000 crores
Retail Individual Investors (RIIs)10%2200000 crores

Gujarat Kidney and Super Speciality Ltd IPO Strengths & Weaknesses

No Data Found
No Data Found

Gujarat Kidney and Super Speciality Ltd IPO Important Dates & Issue Details

Allotment DateListing Date
26 Dec '2530 Dec '25

Gujarat Kidney and Super Speciality Ltd IPO Lot Size and Investment Details

Minimum Lot Size128 shares
Maximum Lot Size (Retail)4352 shares

The lot size of Gujarat Kidney and Super Speciality Ltd ipo has been designed to ensure broad participation while maintaining optimal price discovery.

How to Apply for Gujarat Kidney and Super Speciality Ltd IPO

  1. Log in to your Choice account
  2. Select IPO
  3. Enter the number of lots and your price
  4. Verify UPI ID
  5. Complete the transaction on your UPI app

Gujarat Kidney and Super Speciality Ltd IPO FAQs

The minimum lot size is 128 shares with a price band of ₹108 to ₹114 per share, requiring a minimum investment of ₹14,592.

Check allotment status on the registrar's website using PAN number or application number after the Gujarat Kidney and Super Speciality Ltd ipo allotment date.

The listing date of Gujarat Kidney and Super Speciality Ltd ipo is scheduled for 30 Dec '25 on NSE/BSE .

Investment decisions should be based on your risk appetite, financial goals, and a thorough analysis of the company's fundamentals and growth prospects.

Consider factors like company fundamentals, valuation, market conditions, and your investment portfolio before making any investment decision.